DMTKDermTech, Inc.

Nasdaq dermtech.com


$ 0.36 $ -0.04 (-10.26 %)    

Tuesday, 28-May-2024 15:46:44 EDT
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 0.35
$ 0.36
$ 0.00 x 0
$ 0.00 x 0
$ 0.36 - $ 0.36
$ 0.31 - $ 3.90
531,286
na
12.15M
$ 2.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-02-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-05-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-13-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 06-14-2019 03-31-2019 10-K
22 02-14-2019 12-31-2018 10-Q
23 11-14-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 06-29-2018 03-31-2018 10-K
26 02-13-2018 12-31-2017 10-Q
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 dermtech-q1-2024-adj-eps-058-misses-057-estimate-sales-385m-miss-399m-estimate

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.57) by...

 lake-street-downgrades-dermtech-to-hold-announces-063-price-target

Lake Street analyst Thomas Flaten downgrades DermTech (NASDAQ:DMTK) from Buy to Hold and announces $0.63 price target.

 stephens--co-reiterates-equal-weight-on-dermtech-maintains-15-price-target

Stephens & Co. analyst Mason Carrico reiterates DermTech (NASDAQ:DMTK) with a Equal-Weight and maintains $1.5 price target.

 btig-downgrades-dermtech-to-neutral

BTIG analyst Sung Ji Nam downgrades DermTech (NASDAQ:DMTK) from Buy to Neutral.

 dermtech-intends-to-continue-laboratory-operations-during-strategic-review

The Company anticipates incurring a one-time restructuring charge of approximately $1.6 million in the second quarter of 2024 i...

 dermtech-to-seek-strategic-alternatives-plans-restructuring-actions-that-will-result-in-workforce-reduction-of-100-employees-or-56-of-workforce

Potential strategic alternatives that may be explored or evaluated include an acquisition, merger, reverse merger, business com...

 btig-maintains-buy-on-dermtech-lowers-price-target-to-2

BTIG analyst Mark Massaro maintains DermTech (NASDAQ:DMTK) with a Buy and lowers the price target from $4 to $2.

 stephens--co-maintains-equal-weight-on-dermtech-lowers-price-target-to-15

Stephens & Co. analyst Mason Carrico maintains DermTech (NASDAQ:DMTK) with a Equal-Weight and lowers the price target fr...

 why-zscaler-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION